No AI APIs. Public sources only.

Track biotech catalysts before the market prices them in.

FDA dates, clinical readouts, conferences, SEC filings, and company events in one clean dashboard.

ClinicalTrials.gov, SEC EDGAR, RSS
Change records with old and new values
Supabase, Stripe, Vercel ready

Live workflow

Upcoming catalyst tape

Jun 28

GMAB

exact

Conference update on combination cohorts

Approved/Phase 3ASCO

Jul 10

RVMD

month

RAS(ON) inhibitor expansion cohort update

Phase 2Phase 2 Readout

Jul 24

ALLO

exact

Cell therapy pipeline investor update

Phase 2Investor Day

Aug 15

RCUS

quarter

STAR-221 interim analysis window

Phase 3Phase 3 Readout

Sep 30

EXEL

half year

STELLAR pivotal study top-line data

Phase 3Phase 3 Readout

Oct 1

MRUS

quarter

Combination cohort clinical update

Phase 2Phase 2 Readout

Nov 20

NUVL

quarter

Potential regulatory action window

RegistrationFDA PDUFA

Dec 15

AVBP

month

ClinicalTrials.gov primary completion watch

Phase 3Clinical Trial Completion

Investor dashboard

Compact catalyst tracking

Open calendar
CompanyCatalystAssetPhaseExpectedConfidenceStatus
GMAB
Genmab
Conference update on combination cohorts
ASCO
EpcoritamabApproved/Phase 3ASCO 2026exactupcoming
RVMD
Revolution Medicines
RAS(ON) inhibitor expansion cohort update
Phase 2 Readout
RMC-6236Phase 2July 2026monthactive
ALLO
Allogene Therapeutics
Cell therapy pipeline investor update
Investor Day
Cema-celPhase 2July 24, 2026exactupcoming
RCUS
Arcus Biosciences
STAR-221 interim analysis window
Phase 3 Readout
DomvanalimabPhase 3Q3 2026quarterupcoming
EXEL
Exelixis
STELLAR pivotal study top-line data
Phase 3 Readout
ZanzalintinibPhase 32H 2026half yearupcoming

Pricing

Scale your watchlist

Free

$0

5 companies

Personal watchlist for early evaluation.

  • +Manual catalysts
  • +Public dashboard sample data
  • +CSV export

Pro

$29

50 companies

For active biotech investors tracking a focused universe.

  • +Daily refresh jobs
  • +SEC and RSS monitoring
  • +Change history

Analyst

$99

250 companies

For analysts and teams managing broad coverage lists.

  • +Morning and after-close refresh
  • +ClinicalTrials.gov snapshots
  • +Priority exports